TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥9 | ¥9 | ¥1 | ¥6 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥0 | ¥3 | ¥3 | ¥1 |
| Inventory | ¥6 | ¥5 | ¥5 | ¥5 |
| Other Curr. Assets | ¥0 | ¥0 | ¥1 | ¥0 |
| Total Curr. Assets | ¥15 | ¥17 | ¥9 | ¥12 |
| Property Plant & Equip (Net) | ¥12 | ¥8 | ¥4 | ¥4 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥4 | ¥4 | ¥4 | ¥4 |
| Long-Term Investments | ¥5 | ¥1 | ¥1 | ¥0 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥1 |
| Other NC Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total NC Assets | ¥21 | ¥12 | ¥9 | ¥9 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥37 | ¥29 | ¥19 | ¥21 |
| Liabilities | – | – | – | – |
| Payables | ¥1 | ¥1 | ¥1 | ¥1 |
| Short-Term Debt | ¥6 | ¥5 | ¥4 | ¥2 |
| Tax Payable | ¥0 | ¥2 | ¥0 | ¥4 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥2 | ¥1 | ¥1 | ¥2 |
| Total Curr. Liab. | ¥10 | ¥10 | ¥7 | ¥9 |
| LT Debt | ¥9 | ¥4 | ¥2 | ¥3 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥1 | ¥1 | ¥1 | ¥1 |
| Other NC Liab. | ¥0 | ¥0 | ¥0 | ¥0 |
| Total NC Liab. | ¥10 | ¥5 | ¥4 | ¥5 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥19 | ¥16 | ¥10 | ¥14 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Retained Earnings | ¥14 | ¥11 | ¥6 | ¥4 |
| AOCI | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥17 | ¥14 | ¥8 | ¥7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥37 | ¥29 | ¥19 | ¥21 |
| Net Debt | ¥5 | ¥0 | ¥5 | -¥1 |